Robert is an early-stage therapeutics entrepreneur and operator with over five years of experience in drug discovery and development at biotech startups. As former Director of R&D at Pelagos Pharma and co-founder of Aumenta Biosciences, he led multiple preclinical development programs for both small molecule and biologic therapeutics ranging from discovery stage to completion of IND-enabling studies. Robert joins Yale Ventures with a passion for supporting academic innovators transform their scientific concepts into novel therapeutics.